Xiao-Hui Wen
Papers
1
Total Citations
2
H-Index
1
About
Dr. Xiao-Hui Wen is a pioneering stem cell biologist whose work centers on somatic cell reprogramming and the development of induced pluripotent stem cells (iPSCs) for regenerative medicine. Her most notable contribution is the invention of a robotic-based spatial-restricting structured flow platform, which enables the precise selection of monoclonal cell lineages from heterogeneous reprogramming cultures. This breakthrough directly addresses a critical bottleneck in the field: the contamination of iPSC lines by partially reprogrammed or aberrant cells, which compromises downstream applications. By automating the isolation of high-quality, uniform iPSC clones, Dr. Wen’s technology dramatically improves the reliability and scalability of personalized disease modeling and cell therapy. Although her seminal 2024 paper currently holds 2 citations, its methodological significance is expected to drive substantial future impact. Dr. Wen’s work bridges engineering and biology, offering a transformative tool for regenerative medicine. Her achievements underscore a commitment to overcoming technical barriers in stem cell research, positioning her as a rising leader in the quest for safe, effective iPSC-based therapies.
Research Focus
Key Achievements
Top Papers
- 1